Understanding FDA not Cleared for Post Traumatic Stress Disorder (PTSD)

banner image


Post-Traumatic Stress Disorder (PTSD) is an intense and debilitating anxiety response triggered by experiencing or witnessing a life-threatening or profoundly traumatic event. 

This severe condition often leads individuals to actively avoid places, situations, or even thoughts that remind them of the trauma, significantly impacting their quality of life and hindering their ability to function normally in daily activities for an extended period.


Approximately 8% of the general population will experience PTSD in their lifetime, with an additional 5-15% potentially experiencing sub-clinical forms where symptoms are present but do not meet full diagnostic criteria.


Women are statistically more likely to develop PTSD than men, and it's also more prevalent among young adults, largely due to their higher likelihood of encountering various traumatic events. 

PTSD can affect individuals across all age groups, including children and adolescents. 

Historically, the types of traumatic events leading to PTSD have sometimes differed between genders; for instance, men often develop it after combat exposure, while women more commonly experience it following physical or sexual assault. 

Today, many PTSD cases in the general population stem from exposure to traffic accidents or work-related incidents. 


The disorder is particularly common among war veterans; for example, historical data indicates that 30% of Vietnam War veterans developed PTSD, with another 25% experiencing a sub-clinical form.


While often strongly associated with military combat, it's vital to recognize that PTSD isn't exclusive to veterans; for instance, research shows that many female rape victims no longer meet the diagnostic criteria for PTSD just three months after the assault, highlighting the brain's capacity for recovery given the right support.

Several factors influence a person's likelihood of developing PTSD, including the immediate support they receive after the traumatic event, the broader environment's attitude toward the event, the provision of immediate psychological or medical care (as a lack thereof can perpetuate the condition), and individual predispositions such as genetic vulnerability or pre-existing mental health conditions.



For individuals suffering from PTSD, achieving 'remission' means regaining control over their lives, experiencing a profound reduction in distressing symptoms, and returning to a state of emotional stability and functional well-being. 

Deep TMS treatment offers compelling 'good results' in this journey. By precisely targeting brain areas implicated in PTSD, it helps to significantly alleviate core symptoms like anxiety, intrusive thoughts, and hyperarousal. 

Clinical trials have demonstrated remarkable outcomes, with some studies showing significant improvements in PTSD and co-occurring depressive symptoms in a substantial portion of participants.

Furthermore, specific research in veterans indicated that a high percentage no longer met PTSD diagnostic criteria after receiving TMS therapy. 

These outcomes underscore Deep TMS's potential to help patients overcome the debilitating effects of trauma, leading to enhanced daily functioning, improved quality of life, and a vital step towards sustained recovery and emotional freedom. 


In Summary

Post-Traumatic Stress Disorder (PTSD) is a profound anxiety response to trauma that significantly impairs daily functioning, with current conventional treatments often providing only partial relief for its diverse symptoms. 

Deep TMS offers an innovative, non-invasive, and well-tolerated treatment option. 


By directly stimulating relevant brain networks, Deep TMS aims to bring about significant improvement in symptoms, offering renewed hope for individuals seeking relief and a return to a more fulfilling life beyond the shadow of trauma.

Curious about How BrainsWay Deep TMS® could transform your Health?

BrainsWay Deep TMS® offers innovative approaches not only for neurological and psychiatric conditions. 


Important disclaimer

BrainsWay Deep TMS® Treatment for Post Traumatic Syndrome Disorder is not intended for individuals in the United States as it HAS NOT BEEN FULLY CLEARED by the FDA for safety and efficacy for these specific indications. 


 "It is important to note that while these specific indications may not be FDA-cleared in the United States, some BrainsWay Deep TMS® treatments for certain conditions may have received CE Mark approval in Europe, indicating compliance with European health, safety, and environmental protection standards. Always verify the regulatory status of any treatment in your specific region."